Cited by 39Epilepsy research and treatmentNeuroscience and Neuropharmacology ResearchNerve injury and regeneration

BDNF-TrkB signaling pathway mediates the induction of epileptiform activity induced by a convulsant drug cyclothiazide

Open access
Wang, Yun, Qi, Jin-Shun, Kong, Shuzhen, Sun, Yajie, Fan, Jing, Jiang, Min, Chen, Gong·2009·Neuropharmacology

Abstract

Brain-derived neurotrophic factor (BDNF) and its receptor TrkB play an important function in neuronal development and synaptic plasticity. Recently we have established that cyclothiazide (CTZ) is a novel convulsant drug inducing robust epileptiform activity in hippocampal neurons both in vitro and in vivo. However, the molecular mechanisms underlying such convulsant action of CTZ are unknown. Here, we investigated potential roles of BDNF-TrkB signaling pathway in the CTZ-induction of epileptiform activity. In anaesthetized rats, CTZ dose-dependently induced epileptiform activity characterized by progressing of multiple peaks of population spikes, spontaneous spiking events, and synchronized epileptiform bursts. Pre-injection of a receptor tyrosine kinase inhibitor K252a or a specific antibody for TrkB receptors before intracerebroventricular injection of CTZ significantly suppressed the epileptiform activity induced by CTZ. Similarly, in cultured hippocampal pyramidal neurons, pre-treatment with CTZ together with K252a or TrkB-receptor antibody also inhibited the CTZ-induction of epileptiform activity. Furthermore, we demonstrated that acute application of K252a in hippocampal cultures inhibited epileptiform bursts and action potential firing. We conclude that activation of BDNF-TrkB signaling pathway is fundamentally important during the CTZ-induction of epileptiform activity both in vitro and in vivo.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuropharm.2009.04.007

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Seizures are associated with increased expression of several neurotrophic-related genes, including transcription factors, neuropeptides, and growth factors.

    “Seizures have been associated with an increased expression of several neurotrophic-related genes, including transcription factors [176], neuropeptides [177], and growth factors [178].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wang, Y., Qi, J.-S., Kong, S., Sun, Y., Fan, J., Jiang, M., & Chen, G.
Affiliations
  • Chongqing Technology and Business University (CN)
  • Pennsylvania State University (US)
  • Fudan University (CN)
Corresponding author
  • Wang, Yun
  • Chen, Gong
Venue
Neuropharmacology
Publisher
Elsevier BV
Published
2009-07
Volume
57
Issue
1
Pages
49-59
ISSN
0028-3908 (ISSN-L)
OpenAlex
W1979787584
Cited by
39
References
42
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 4 · 2022: 3 · 2018: 3 · 2017: 2 · 2016: 1 · 2015: 5 · 2014: 4 · 2013: 5 · 2012: 3
FWCI
1.44
Type
journal article
Language
en
Open access
Locations
  • Neuropharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Natural Science Foundation of China
  • National Institute of Neurological Disorders and Stroke (R21NS054858, NS054858)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
Keywords
BDNF/TrkB signaling, cyclothiazide, epileptiform activity, convulsant drugs, K252a, TrkB receptor, hippocampal neurons, receptor tyrosine kinase, seizure induction, population spike, action potential firing
MeSH terms
Action Potentials, Analysis of Variance, Animals, Antibodies, Antihypertensive Agents, Benzothiadiazines, Carbazoles, Disease Models, Animal, Dose-Response Relationship, Drug, Enzyme Inhibitors, Epilepsy, Hippocampus, Male, Neurons, Time Factors, Signal Transduction, Rats, Sprague-Dawley, Brain-Derived Neurotrophic Factor, Receptor, trkB, Indole Alkaloids, Rats, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review